Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo - PubMed (original) (raw)
Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo
V Mohamed-Ali et al. J Clin Endocrinol Metab. 1997 Dec.
Abstract
We measured arterio-venous differences in concentrations of tumor necrosis factor-alpha (TNF alpha) and interleukin-6 (IL-6) across a sc adipose tissue bed in the postabsorptive state in 39 subjects [22 women and 17 men; median age, 36 yr (interquartile range, 26-48 yr); body mass index, 31.8 kg/m2 (range, 22.3- 38.7 kg/m2); percent body fat, 28.7% (range, 17.6-50.7%)]. A subgroup of 8 subjects had arteriovenous differences measured across forearm muscle. Thirty subjects were studied from late morning to early evening; 19 ate a high carbohydrate meal around 1300 h, and 11 continued to fast. We found a greater than 2-fold increase in IL-6 concentrations across the adipose tissue bed [arterial, 2.27 pg/mL (range, 1.42-3.53 pg/mL); venous, 6.71 pg/mL (range, 3.36-9.62 pg/mL); P < 0.001], but not across forearm muscle. Arterial plasma concentrations of IL-6 correlated significantly with body mass index (Spearman's r = 0.48; P < 0.01) and percent body fat (Spearman's r = 0.49; P < 0.01). Subcutaneous adipose tissue IL-6 production increased by the early evening (1800-1900 h) in both subjects who had extended their fasting and those who had eaten. Neither deep forearm nor sc adipose tissue consistently released TNF alpha [across adipose tissue: arterial, 1.83 pg/mL (range, 1.36-2.34 pg/mL); venous, 1.85 pg/mL (range, 1.44-2.53 pg/mL); P = NS: across forearm muscle: arterial, 1.22 pg/mL (range, 0.74-2.76 pg/mL); venous, 0.99 pg/mL (range, 0.69-1.70 pg/mL); P = NS]. Although both IL-6 and TNF alpha are expressed by adipose tissue, our results show that there are important differences in their systemic release. TNF alpha is not released by this sc depot. In contrast, IL-6 is released from the depot and is thereby able to signal systemically.
Similar articles
- Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo.
Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW. Mohamed-Ali V, et al. Am J Physiol. 1999 Dec;277(6):E971-5. doi: 10.1152/ajpendo.1999.277.6.E971. Am J Physiol. 1999. PMID: 10600783 - Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue.
Krogh-Madsen R, Plomgaard P, Keller P, Keller C, Pedersen BK. Krogh-Madsen R, et al. Am J Physiol Endocrinol Metab. 2004 Feb;286(2):E234-8. doi: 10.1152/ajpendo.00274.2003. Epub 2003 Oct 7. Am J Physiol Endocrinol Metab. 2004. PMID: 14532168 - Skeletal muscle insulin resistance in morbid obesity: the role of interleukin-6 and leptin.
Mitrou P, Lambadiari V, Maratou E, Boutati E, Komesidou V, Papakonstantinou A, Raptis SA, Dimitriadis G. Mitrou P, et al. Exp Clin Endocrinol Diabetes. 2011 Sep;119(8):484-9. doi: 10.1055/s-0030-1269846. Epub 2011 Aug 2. Exp Clin Endocrinol Diabetes. 2011. PMID: 21811961 - Searching for the exercise factor: is IL-6 a candidate?
Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, Febbraio M, Saltin B. Pedersen BK, et al. J Muscle Res Cell Motil. 2003;24(2-3):113-9. doi: 10.1023/a:1026070911202. J Muscle Res Cell Motil. 2003. PMID: 14609022 Review. - The controversial role of IL-6 in adipose tissue on obesity-induced dysregulation of glucose metabolism.
Wueest S, Konrad D. Wueest S, et al. Am J Physiol Endocrinol Metab. 2020 Sep 1;319(3):E607-E613. doi: 10.1152/ajpendo.00306.2020. Epub 2020 Jul 27. Am J Physiol Endocrinol Metab. 2020. PMID: 32715746 Review.
Cited by
- Obesity-Associated Breast Cancer: Analysis of Risk Factors and Current Clinical Evaluation.
Engin A. Engin A. Adv Exp Med Biol. 2024;1460:767-819. doi: 10.1007/978-3-031-63657-8_26. Adv Exp Med Biol. 2024. PMID: 39287872 Review. - Mechanisms by which obesity regulates inflammation and anti-tumor immunity in cancer.
Miracle CE, McCallister CL, Egleton RD, Salisbury TB. Miracle CE, et al. Biochem Biophys Res Commun. 2024 Nov 12;733:150437. doi: 10.1016/j.bbrc.2024.150437. Epub 2024 Jul 23. Biochem Biophys Res Commun. 2024. PMID: 39074412 Review. - Mapping pathways to neuronal atrophy in healthy, mid-aged adults: From chronic stress to systemic inflammation to neurodegeneration?
Schaefer JK, Engert V, Valk SL, Singer T, Puhlmann LMC. Schaefer JK, et al. Brain Behav Immun Health. 2024 Apr 24;38:100781. doi: 10.1016/j.bbih.2024.100781. eCollection 2024 Jul. Brain Behav Immun Health. 2024. PMID: 38725445 Free PMC article. - Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review).
Varra FN, Varras M, Varra VK, Theodosis-Nobelos P. Varra FN, et al. Mol Med Rep. 2024 Jun;29(6):95. doi: 10.3892/mmr.2024.13219. Epub 2024 Apr 12. Mol Med Rep. 2024. PMID: 38606791 Free PMC article. Review. - Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis.
Tylutka A, Walas Ł, Zembron-Lacny A. Tylutka A, et al. Front Immunol. 2024 Mar 1;15:1330386. doi: 10.3389/fimmu.2024.1330386. eCollection 2024. Front Immunol. 2024. PMID: 38495887 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous